跳至主要内容
临床试验/CTRI/2022/07/044023
CTRI/2022/07/044023尚未招募4 期

Randomised control study of intravenous ferric carboxymaltose versus iron sucrose in treatment of iron deficiency anemia among antepartum women

none0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • pregnant women between gestation age 16-34 weeks with Hb between 7-9.9 gm/dl and failed oral supplementation therapy of iron.

排除标准

  • pregnant patients with allergy to iron therapy previously, known medical illness such as asthma, thromboembolism, requiring emergency cesarean section and negative consent. patient who requires blood transfusion for severe anemia

研究者

发起方
none

相似试验